ClinicalTrials.gov
ClinicalTrials.gov Menu

A Dose Escalation Study of the Safety and Pharmacokinetics of GSK1363089 (Formerly XL880) Administered Orally Daily to Subjects With Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00743067
Recruitment Status : Completed
First Posted : August 28, 2008
Last Update Posted : July 26, 2017
Sponsor:
Information provided by (Responsible Party):
GlaxoSmithKline